PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31392398-8	2019	Multiple genes related to chemotaxis, IL-1, chemokines, regulation of inflammation, and extracellular signal-regulated kinases (ERK) were upregulated in lungs of mice treated with bleomycin and MIA-602.	Bleomycin	180-189	interleukin 1 complex	Mus musculus	38-42	
28678919-6	2017	As a result, cell viability was significantly decreased, as well as apoptosis and the expression of IL-1 and TNF-alpha were remarkably increased after 50 and 100 mug/mL of bleomycin administration.	Bleomycin	172-181	interleukin 1 complex	Mus musculus	100-104	
2426952-13	1986	In contrast, bleomycin treatment caused a reduction in alveolar macrophage interleukin-1 (IL-1) production, and NDGA treatment did not alter this reduction, which suggests that MDGF is separate from IL-1 in this case, and that MDGF played a more dominant role, at least in this model of pulmonary fibrosis.	Bleomycin	13-22	interleukin 1 complex	Mus musculus	90-94	
17992263-6	2007	Exogenous rIL-1beta recapitulated a high degree of bleomycin-induced lung pathology, and specific blockade of IL-1R1 by IL-1 receptor antagonist dramatically reduced bleomycin-induced inflammation.	Bleomycin	51-60	interleukin 1 complex	Mus musculus	11-15	
17992263-8	2007	In conclusion, bleomycin-induced lung pathology required the inflammasome and IL-1R1/MyD88 signaling, and IL-1 represented a critical effector of pathology and therapeutic target of chronic lung inflammation and fibrosis.	Bleomycin	15-24	interleukin 1 complex	Mus musculus	78-82	
17569781-7	2007	Therefore, MSCs protect lung tissue from BLM-induced injury by blocking TNF-alpha and IL-1, two fundamental proinflammatory cytokines in lung.	Bleomycin	41-44	interleukin 1 complex	Mus musculus	86-90